Allos Pharma Inc., a US-based biopharmaceutical company specialising in the development of treatments for rare neurological disorders, announced on Monday that it has expanded its intellectual property rights for Arbaclofen with a new patent family that was filed to the United States Patent Trademark & Office earlier in 2023.
This new patent family is in addition to the company's present granted patent family.
The company also has worldwide exclusive rights to granted patents and clinical programs for arbaclofen in further indications, which includes autism spectrum disorder. This is in addition to the present Fragile X Syndrome development program, for which there are no approved medications, and where the product has Orphan Drug Designation.
Dr Randall Carpenter, MD, co-founder of Allos Pharma Inc, said: "This license builds upon the progress in our Fragile X Syndrome program, where we have achieved alignment with the fragile X community and the FDA on the design of the confirmatory Phase 3 clinical trial. We are excited to have the rights to develop arbaclofen in additional indications as clear efficacy signals were observed in recent trials in individuals with idiopathic Autism Spectrum Disorder."
Pfizer's Hympavzi (marstacimab-hncq) receives US FDA approval for Hemophilia A or B treatment
Capricor begins BLA submission for deramiocel in Duchenne muscular dystrophy
GE HealthCare expands AI-enabled enterprise imaging with Blackford integration
Biogen receives FDA Breakthrough Therapy Designation for felzartamab
Inspira Technologies develops new disposable kit for perfusion market
Ananda Developments PLC signs contract for Phase 1 PK study on MRX1
Teva's Prolia biosimilar candidate accepted for review by FDA and EMA
Boehringer receives Breakthrough Therapy designation for survodutide
GBI Biomanufacturing agrees manufacturing collaboration with Allterum Therapeutics
Genprex research collaborators to present positive data on Reqorsa Gene Therapy at SITC 2024
ALK secures U.S. FDA approval for AccuTest Allergy Skin Testing Devices